ClinicalTrials.gg
RecruitingNCT05798494PREPARE CHILDUpdated Nov 12, 2026

PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus

An interventional study of Weight loss intervention in Overweight and Obesity, Weight Loss and Pregnancy Related, sponsored by Ulla Kampmann Opstrup. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 38 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Primary conditionObesityRegistry: OverweightReclassifiedWhy we changed it
Registry
Overweight — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity
Why
  1. The study's listed conditions name Obesity, a narrower term within Overweight.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Ulla Kampmann Opstrup · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jun 2023; still recruiting 3 years 5 months later.
Updated Nov 12, 2026Primary completion movedStudy completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 38 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 351 studies in Obesity with a site in Denmark — 58 open to participants now, 85 under way, 23 of them phase 3. Obesity · Denmark.

Planned enrollment
146th of 283
66 · median 72
Started
2023
with 17 others
No phase
187 of 351
24 open now
Primary completion
2029-12
later than 79 of 84 live
Registered
262nd of 351
by date

Among the 351 studies in Obesity with a site in Denmark, this one is the 146th largest by planned enrollment of the 283 interventional ones that give a count, is one of 18 that started in 2023, is one of 187 with no phase, reaches primary completion later than 79 of the 84 other live ones, and was the 262nd registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

58 of the 351 studies in Obesity with a site in Denmark are open now. Recruiting first, the newest first:

53 more — sign in →

All 58 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 38 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 351 studies in Obesity with a site in Denmark, or all of them as a file.
02

Study summary

The study is a single site parallel randomized controlled study. The study will be assessing the effect of a 10% pre-conceptional weight loss intervention vs a control group among healthy couples where the prospective mother is pregnant and overweight or obese (BMI 27-44.9 kg/m\^2). The couples in intervention group will receive dietitian counseling and participate in physical activity sessions to attain the 10% weight loss. The overall objective is to test whether a comprehensive pre-conceptional parental weight loss intervention effectively reduces the risk of offspring overweight, and adiposity and its complications compared to a control group.

Read the detailed description

The study is a single site parallel randomized controlled study. The study will be assessing the effect of a pre-conceptional weight loss intervention vs a control group among healthy couples where the prospective mother is pregnant (recruited at gestational week 18-36), overweight or obese (BMI 27-44.9 kg/m\^2), between 18-38 years and planning an additional pregnancy within the following 3 years.

The investigators will recruit a total of 66 healthy pregnant couples who will be randomized 1:1 to either intervention or control, stratified according to maternal pre-pregnancy BMI and previous or present diagnosis of gestational diabetes.

The couples in intervention group will receive dietary counseling by a dietitian from 3 months post-partum of the 1st child until birth of the 2nd child. The goal is to achieve a healthy lifestyle and a moderate weight loss of 10% according to pre-pregnancy weight during the first year. Hereafter, the couples will be guided in weight maintenance until pregnancy of the second child. During pregnancy the goal is to achieve a healthy weight gain. Couples in intervention group will also participate in physical activity sessions every 2nd week and will be advised to engage at least 150 minutes of moderate physical activity per week.

The overall objective is to test whether a comprehensive pre-conceptional parental weight loss intervention effectively reduces the risk of offspring overweight, and adiposity and its complications compared to a control group. The 1st baby born before intervention is started will be the "index child" and the metabolic and anthropometric parameters of the 1st child will be compared to parameters of the second child to assess the effect of the parent's healthy lifestyle between the two pregnancies.

The investigators hypothesize that parental weight loss intervention, initiated before conception, will facilitate lower parental insulin resistance, inflammation, body weight and adiposity, incretin responses and energy expenditure compared to usual care. For the offspring the investigators hypothesize that the intervention will reduce adverse pregnancy outcomes with a short-term reduction in the risk of being born large for gestational age with excessive fat mass and a long-term reduction in the risk of developing overweight or obesity as a consequence of both social (family approach) and biological (epigenetic modifications) pathways.

03

Conditions studied

  • Overweight and Obesity
  • Weight Loss
  • Pregnancy Related
  • Child Nutrition Sciences
  • Body Composition

Browse trials for

Keywords

  • Overweight
  • Pregnancy
  • Weight loss
  • Diet, Reducing
  • Epigenetics
  • Healthy Lifestyle
  • DNA Methylation
  • Exercise
  • Offspring's neonatal fat mass
  • Pea Pod
  • Infant, Large for Gestational Age
  • Body Fat Distribution
04

In context

Obesity Reclassified

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

This study's planned enrollment of 66 is close to the median of 67 across 9,043 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

This is the only study on the registry with Ulla Kampmann Opstrup as lead sponsor.

Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

The criteria were revised on the registry on Nov 12, 2026. See what changed

Ages eligible
18 Years to 38 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Maternal inclusion Criteria:

  • Maternal pre-pregnancy 27.0-44.9 kg/m\^2
  • Maternal age range 18-38 years
  • Connected to Aarhus University Hospital or Viborg Regional Hospital in Denmark as place of birth
  • Pregnant

Paternal Inclusion Criteria:

  • Paternal pre-pregnancy BMI 18.5-44.9 kg/m\^2
  • Paternal age range 18-55 years

Parental Inclusion Criteria:

  • Couples (male and female)
  • Planning pregnancy within 3 years
  • Provided voluntary
  • Danish or English speaking
  • Intention to permit the planned offspring to participate in the follow-up study
  • Able to store biological samples from the offspring at home in the freezer in a box given by the study personnel

Parental Exclusion Criteria:

  • Diabetes mellitus (Type 1 or 2)
  • Previous or present eating disorder
  • Allergy towards ingredients in the very low calorie diet products
  • Severe heart, liver or kidney disease
  • Conception by in vitro fertilization
  • Any medical condition or concomitant medication as judged by the medical responsible
  • Adherence to vegan diets or other diets interfering with the dietary guidelines in the study
  • Participation in other clinical trial that can affect the results of the current study
  • Engagement in elite sports or similar strenuous exercise ≥5 h/week at inclusion
  • Blood donation or transfusion within the past month before screening
  • Blood donation during the study
  • Inability or unwillingness to follow the study protocol and instructions given by the study personnel

A detailed description of the exclusion criteria is given below:

Medical conditions as known by the participant:

  • Diabetes mellitus (type 1 and 2)
  • History or diagnosis of eating disorder (e.g. restrained eating, disinhibition, emotional eating)
  • Any significant medical condition as assessed by the investigator (e.g. dysregulated thyroid disease or reproductive diseases)
  • Any significant psychiatric disorder (i.e. schizophrenia, bipolar disease or depression) as assessed by the investigator
  • Severe chronic heart, liver and kidney disease
  • Polycystic ovary syndrome with irregular cycle

Medication:

  • Current use of medication or use within the previous three months with a potential to affect body weight or pregnancy as judged by the investigator (e.g. systemic corticoids)

Personal/other:

  • Severe food allergies, food intolerances or dislike expected to interfere with the study, including allergy towards ingredients in the VLCD products
  • Engagement in elite sports or similar strenuous exercise ≥5 h/week
  • Blood donation or transfusion within the past month before screening
  • Planned blood donation for other purpose than this study during participation
  • Alcohol abuse, as judged by the investigator, within the previous 12 months
  • Drug abuse, as judged by the investigator, within the previous 12 months
  • Psychological or behavioral problems which, in the judgement of the investigator, would lead to difficulty in complying with the study protocol
  • Participation in other clinical trials within the past three months or intention to do so during the study, which are judged by the investigator to affect the present study
  • Unable to consume the interventional product for religious reasons, swallowing disorders, other physiological reasons or any other reasons for not being able to follow the recommended diet
  • Inability or unwillingness to give written informed consent or communicate with study personnel
  • Inability or unwillingness to follow the study protocol and instructions given by the study personnel
  • Illiteracy or inadequate understanding of Danish or English language.
  • Any other condition that judged by the investigator may interfere with the adherence to the study protocol
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Intervention

    Intervention group will receive dietary counseling by a trained dietitian from 3 months post-partum of the 1st child until birth of the 2nd child. The mother will receive advice to provide a moderate caloric restriction (-500 to 1000 kcal/d) and attend physical activity sessions to attain a 10 % weight loss according to pre-pregnancy weight. If the father is also overweight or obese, he will receive the same advice.

    Behavioral: Weight loss intervention

  • No intervention
    Control

    The control group will receive standard care and will not receive any dietary advice prior to pregnancy. During pregnancy control subjects will receive dietary advice according to standard care which means no counselling from a dietitian unless there are special needs (e.g., gestational diabetes), then they will receive counseling from a dietitian in accordance with standard care.

Interventions

  • BehavioralWeight loss intervention

    Subjects will receive dietary counseling by a dietitian from 3 months post-partum of the 1st child until birth of the 2nd child. The mother (and father if overweight, BMI ≥25 kg/m\^2) will receive advice to provide a moderate caloric restriction (-500 to 1000 kcal/d) and will be advised to engage in at least 150 minutes of moderate-intensity physical activity per week, including physical activity sessions every 2nd week, with a target weight loss of approximately 0,5-1,0 kg/week. The weight loss will last until a 10% weight loss (according to pre-pregnancy weight) has been achieved or until 1-year post-partum. If the subject has not achieved a weight loss of 10%, she or he will be offered Very low-calorie diet (VLCD) until target weight loss is reached. After weight loss subjects will receive counseling to maintain weight loss and healthy weight gain during pregnancy until birth of the 2nd child.

07

What researchers measure

Primary outcomes

  1. Neonatal fat mass

    Offspring's neonatal fat mass (grams) assessed by air displacement plethysmography (Pea POD)

    Time frame: Collected within the first week of birth (strived <48 hours)

  2. Difference in epigenetic changes in child 1 and 2

    Cord blood from offspring will be collected at birth and stored at -70 °C or lower until use. At the Department of Molecular Medicine AUH genomic DNA will be extracted and methylation levels are measured using standard arrays and protocols. Methylation levels will be reported as beta-values, reflecting the proportion of methylated CpG sites (range: 0 to 1), assuming a binomial distribution at each site. As no other studies have performed DNA methylation analysis using Illumina EPIC arrays in similar cohorts, precise power calculations are difficult. However, the EPICOM study, which included 20 cases and 20 matched controls, identified several differentially methylated CpGs using a false discovery rate cutoff \<0.05 with the Illumina 450K methylation array. Therefore, we estimate that a sample size of at least 40 cases is needed in our sibling design to be considered sufficient.

    Time frame: Assessed at birth

Secondary outcomes

  1. Obstetrics outcome - length of gestational age

    Length of gestational age

    Time frame: Assessed at birth of both offsprings

  2. Obstetric - medication use

    Medication use during labor

    Time frame: Collected from initiation of labor until completed birth of both offsprings

  3. Obstetric - delivery mode

    Delivery mode (rupture of membranes or premature contractions, vaginal, cesarean section, instrumental delivery, miscarriage and stillbirth).

    Time frame: Collected at birth of both offsprings

  4. Obstetric - pregnancy complications

    Pregnancy complications e.g. miscarriage, abortion (induced and indication for abortion), hydramnios, gestational hypertension, preeclampsia, need for maternal corticosteroid treatment for fetal lung maturation, urinary tract infection) will be collected from medical record.

    Time frame: Collected at gestational age (GA) 34-36 and after birth of both offsprings

  5. Obstetric - Neonatal unit admissions

    Neonatal unit admissions

    Time frame: Collected at birth and until 12 months after birth of both offsprings

  6. Obstetric - obstetrics complications

    Obstetrics complications (e.g. preterm prelabour rupture of the membranes, shoulder dystocia, birth trauma (perinatal rupture), postpartum hemorrhage, maternal infections, maternal hospitalization).

    Time frame: Collected at birth of both offsprings

  7. Obstetrics - birth defects/abnormalities

    Birth defects/abnormalities

    Time frame: Collected at birth of both offsprings

  8. Neonatal morbidities

    Neonatal morbidity (e.g. major congenital malformations (ICD10 Q00-Q99 or requiring medical or surgical treatment), birth injury, respiratory distress, transient tachypnoea, neonatal hypoglycemia, systemic infections, admission to neonatal intensive care unit, number of admission days, hyperbilirubinemia), deaths.

    Time frame: Collected at birth of both offsprings

  9. Fetal and offspring growth - body weight

    Fetal body weight will be measured with ultrasound during pregnancy and offspring body weight will be measured using an electronic scale.

    Time frame: Collected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3 and 12 months after birth of both offsprings

  10. Fetal and offspring growth - length

    Fetal length will be measured with ultrasound during pregnancy and offspring length will be measured using an infantometer as appropriate for measuring infant, baby and toddler length.

    Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings

  11. Fetal and offspring growth - abdominal circumference

    Abdominal circumference will be measured with ultrasound during pregnancy and offspring abdominal circumference will be measured three times to the nearest 0.1 cm using a stretch-resistant measuring tape

    Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings

  12. Fetal and offspring growth - crown circumference

    Crown circumference will be measured with ultrasound during pregnancy and offspring crown circumference will be measured three times to the nearest 0.1 cm using a stretch-resistant measuring tape

    Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings

  13. Fetal and offspring growth - femur length

    Femur length will be measured with ultrasound during pregnancy

    Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies,

  14. Offspring growth - BMI z-score

    Offspring body mass index (BMI) z-score (BMI adjusted for age and sex).

    Time frame: Collected at birth and 3 and 12 months after birth of both offsprings

  15. Offspring growth - weight for gestational age

    Weight for gestational age. Measured as percent of normal weight related to gestational age.

    Time frame: Collected at birth and 3 and 12 months after birth of both offsprings

  16. Offspring growth - large for gestational age

    Large for gestational age. Prevalence of infants being large for gestational age (LGA).

    Time frame: Collected at birth of both offsprings

  17. Offspring growth - small for gestational age

    Small for gestational age. Prevalence of offspring being small for gestational age (SGA).

    Time frame: Collected at birth of both offsprings

  18. Offspring growth - apgar score

    Apgar score (0-10). The higher the score, the better health condition of the offspring)

    Time frame: Collected at birth of offspring of both offsprings

  19. Offspring growth

    Offspring circumference (thigh, hip and upper arm) and skinfold (subscapularis and suprailiac). Circumferences will be measured to the nearest 0.1 cm using a stretch-resistant measuring tape and skinfolds are measured to the nearest 0.2 mm using a caliper to lightly pinch the skin and the underlying fat.

    Time frame: Collected at birth and 3 and 12 months after birth of offspring.

  20. Offspring growth - body composition by the POD system

    Offspring fat free mass (g) and fat mass (g) will be assessed by air displacement plethysmography using the POD system (Pea POD for 1-8kg)

    Time frame: Collected within the first week of birth and 3 months post partum in both offsprings

  21. Offspring blood pressure

    Offspring blood pressure (diastolic and systolic blood pressure) will be measured three times after 10 minutes rest using an automated device placed on the arm and in direct contact with the skin.

    Time frame: Collected 12 months after birth of both offsprings

  22. Offspring heart rate

    Offspring heart rate will be measured three times after 10 minutes rest using an automated device placed on the arm and in direct contact with the skin.

    Time frame: Collected 12 months after birth of both offsprings

  23. Offspring growth - self-reported body weight

    Self-reported body weight

    Time frame: 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age

  24. Offspring growth - self-reported height

    Self-reported height

    Time frame: 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age

  25. Adult weight

    Adult body weight is measured to the nearest 0.1 kg using a calibrated scale

    Time frame: Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)

  26. Adult Height

    Adult height will be measured to the nearest 0.5 cm using a wall-mounted stadiometer.

    Time frame: Collected in GA34-GA36 in index pregnancy

  27. Adult BMI

    Calculated as weight (kg)/height(m)\^2

    Time frame: Collected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3 and 12 mo. pp of 2nd child).

  28. Adult anthropometric

    Waist- and hip circumference will be measured to the nearest 0.1 cm. During pregnancy and at birth the waist of the female will not be measured.

    Time frame: Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)

  29. Adult blood pressure

    Blood pressure (diastolic and systolic blood pressure) will be measured three times with two minutes apart in right arm after 15 minutes rest using a validated automatic device. The reading is recorded to the nearest 1 mmHg.

    Time frame: Collected at GA34-36 in 1st pregnancy, study visits 3, 12 and 24 months pp. of 1st child, GA34-36 in 2nd pregnancy and 3 months pp after 2nd child

  30. Adult heart rate

    Heart rate will be measured three times with two minutes apart in right arm after 5-10 minutes rest using a validated automatic device. The reading is recorded to the nearest 1 beats/minute for heart rate

    Time frame: Collected at GA34-36 in 1st pregnancy, study visits 3, 12 and 24 months pp. of 1st child, GA34-36 in 2nd pregnancy and 3 months pp after 2nd child

  31. Adult resting metabolic rate

    Resting metabolic rate (calories/24-h) will be measured by indirect calorimetry using a ventilated hood system. Participants will lie in the supine position and rest for 15-20 min before measurements commence. The measurement will last for 15 min.

    Time frame: Collected at study visit 3, 12, and 24 months pp after 1st child.

  32. Adult resting respiratory quotient + substrate

    Resting respiratory quotient (RQ), will be measured by indirect calorimetry using a ventilated hood system. Participants will lie in the supine position and rest for at least 30 min before measurements commence. The measurement will last for 20 min. Lipid, glucose and protein oxidation will be estimated.

    Time frame: Collected at study visit 3, 12, and 24 months pp after 1st child.

  33. Adult medication use

    Use of medication will be collected throughout the study and for each medication the start date, stop date or continuing, form and indication will be noted in appropriate form.

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st. child

  34. Offspring medication use

    Use of medication will be collected throughout the study and for each medication the start date, stop date or continuing, form and indication will be noted in appropriate form.

    Time frame: Birth, after 3 and 12 months after birth of both offsprings

  35. Adult reproduction - Time to pregnancy

    Duration of time to conception defined from selfreported time point they started to try get pregnant to registration of pregnancy. The time of conception will be calculated from the ultrasound scan in week 12

    Time frame: Registration of 2nd. pregnancy (up to tree years from birth of 1.st. child)

  36. Adult glucose metabolism (OGTT)

    3-h oral glucose tolerance test (OGTT) will be performed at with 75g of glucose dissolved in 250 ml of water and added 1 gram of paracetamol. Blood will collected for measurements of blood glucose, hormones (insulin, C-Peptide, glucagon), paracetamol, glucagon-like-peptide-1 (GLP-1), Glucose insulinotropic polypeptide (GIP) and metabolites (FFA). Blood samples will be drawn at time 0, 15, 30, 45, 60, 90, 120 and 180 min

    Time frame: Performed at study visits 3, 12 and 24 months pp of 1st. child

  37. Adult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female)

    OGTT performed during pregnancy according to the screening guidelines for GDM will be obtained from the mother's medical journal in both pregnancies. Performed after risk score at gestational age\~20 and \~28 or only \~28. If, due to weight loss, the participant no longer fulfils the screening criteria for an OGTT in the second pregnancy, she will be offered an OGTT at the same GW as in the first pregnancy as part of the project.

    Time frame: Collected in GA28 of 1st and 2nd pregnancy

  38. Placenta - weight (gram)

    Placenta weight from patient record will be registered

    Time frame: Collected at birth of both offsprings

  39. VO2-max adult - cardiorespiratory fitness

    The VO2-max test will be performed as an incremental exercise test on a bicycle ergometer.

    Time frame: Collected at study visit 3, 12 and 24 months pp after birth of 1st child

  40. Cardiac function offspring - Left ventricular and right ventricular morphology

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Interventricular septal thickness diastole and valve- and chamber dimensions will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  41. Cardiac function offspring - left centricular ejection fraction

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of left ventricular ejection fraction will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  42. Cardiac function offspring - fractional shortening

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of fractional shortening will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  43. Cardiac function offspring - Systolic function, strain

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  44. Cardiac function offspring - Systolic function, strain rate

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain rate will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  45. Cardiac function offspring - TAPSE and RV fractional area change

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of TAPSE and RV fractional area change will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  46. Cardiac function offspring - Diastolic function, left ventricular E/A-ratio

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of left ventricular E/A-ratio will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  47. Cardiac function offspring - Diastolic function, tissue velocities (E', A', S')

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of tissue velocities (E', A', S') will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  48. Cardiac function offspring - Diastolic function, strain

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  49. Cardiac function offspring - Overall cardiac function

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Myocardial performance index (MPI) and cardiac torsion will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  50. Cardiac function offspring - Pulmonary artery acceleration time

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Pulmonary artery acceleration time will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  51. Cardiac function offspring - Pulmonary artery pressure

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Pulmonary artery pressure will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  52. Cardiac function offspring - Persistent ductus arteriosus (PDA)

    ECG and echocardiography will be performed according to standard imaging protocol. Assessment of PDA open or closed and PDA shunt will be done.

    Time frame: Collected at birth and at 12 months follow up visit after birth of each child

  53. Cord blood - Telomore length

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Telomore length.

    Time frame: Collected at birth of both offsprings

  54. Cord blood - pH

    Cord blood pH from patient record will be registered

    Time frame: Collected at birth

  55. Cord blood - Epigenetics

    Epigenetics analyses from whole blood. Will be analysed for methylation changes. metabolomics and exosome.

    Time frame: Collected at birth of both offsprings

  56. Adult body composition by DEXA scan

    Lean mass (g), fat mass (g), abdominal fat (g), visceral fat (g) assessed by a Dual-energy X-ray absorptiometry (DEXA) -scan .

    Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child

  57. Adult bone markers by DEXA scan - bone mineral content

    Bone mineral content (g) assessed by a Dual-energy X-ray absorptiometry-scan.

    Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child

  58. Adult bone markers by DEXA scan - bone area

    Bone area (cm\^2) assessed by a Dual-energy X-ray absorptiometry-scan.

    Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child

  59. Adult bone markers by DEXA scan - bone mineral density

    Bone mineral density (g/cm\^2) assessed by a Dual-energy X-ray absorptiometry-scan.

    Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child

  60. Adult blood sample - glucose

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for glucose

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  61. Adult blood sample - CD163

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for CD163

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  62. Adult blood sample - HbA1c

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for markers of glucose metabolism HbA1c

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  63. Adult blood sample - Kreatinin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for kreatinin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  64. Adult blood sample - eGFR

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for kreatinin and GFR will be estimated

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  65. Adult blood sample - C-reaktivt protein (CRP)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for CRP

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  66. Adult blood sample - Alanintransaminase (ALAT)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for ALAT

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  67. Adult blood sample - Gamma-GT (GGT)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for GGT

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  68. Adult blood sample - Basisk fosfatase (BASP)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for BASP

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  69. Adult blood sample - Bilirubin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Bilirubin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  70. Adult blood sample - Ferritin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Ferritin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  71. Adult blood sample - Hemoglobin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Hemoglobin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  72. Adult blood sample - Leukocytter

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Leucocytter

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  73. Adult blood sample - platelets

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for platelets

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  74. Adult blood sample - Triglyceride

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for triglyceride

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  75. Adult blood sample - Cholesterol HDL

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cholesterol HDL

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  76. Adult blood sample - Cholesterol LDL

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cholesterol LDL

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  77. Adult blood sample - Total Cholesterol

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Total Cholesterol

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  78. Adult blood sample - vitamin B12

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for B12

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  79. Adult blood sample - vitamin D3

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for vitamin D3

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  80. Adult blood sample - c-peptide

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for c-peptide

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  81. Adult blood sample - Insulin-like Growth Factor-1 (IGF-1)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGF-1

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  82. Adult blood sample - Insulin-like growth factor-binding protein-1 (IGFBP-1)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGFBP-1

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  83. Adult blood sample - Insulin-like growth factor-binding protein-3 (IGFBP-3)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGFBP-3

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  84. Adult blood sample - Fibroblast growth factor 21 (FGF-21)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for FGF-21

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  85. Adult blood sample - Leptin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Leptin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  86. Adult blood sample - Adiponectin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Adiponectin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  87. Adult blood sample - Ghrelin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Ghrelin

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  88. Adult blood sample - Growth Hormone (GH)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for GH

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  89. Adult blood sample - Free fatty Acids (FFA)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for FFA

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  90. Adult blood sample - Interleukin 6 (IL-6)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-6

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  91. Adult blood sample - Interleukin 6 (IL-10)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-10

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  92. Adult blood sample - Interleukin-1 alpha (IL-1 alpha)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-1 alpha

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  93. Adult blood sample - Interferon gamma (IFN-γ)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IFN-γ

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  94. Adult blood sample - Tumor Necrosis Factor alfa (TNF-α)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for TNF-α

    Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child

  95. Adult female blood sample - Humant choriogonadotropin (hCG)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for hCG

    Time frame: Collected at GA34-GA36 in both pregnancies

  96. Adult female blood sample - Progesterone

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Progesterone

    Time frame: Collected at GA34-GA36 in both pregnancies

  97. Adult female blood sample - Proinsulin C-peptide

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Proinsulin C-peptide

    Time frame: Collected at GA34-GA36 in both pregnancies

  98. Adult female blood sample - sex hormone binding globulin (SHBG)

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for SHBG

    Time frame: Collected at GA34-GA36 in both pregnancies

  99. Adult female blood sample - Prolactin

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Prolactin

    Time frame: Collected at GA34-GA36 in both pregnancies

  100. Adult blood sample -Cortisol

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cortisol

    Time frame: Collected at GA34-GA36 in both pregnancies

  101. Adult female blood sample -Estradiol

    All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Estradiol

    Time frame: Collected at GA34-GA36 in both pregnancies

  102. Offspring blood sample - glucose

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for glucose

    Time frame: Collected 12 months after birth in both offsprings

  103. Offspring blood sample - c-peptide

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for c-peptide

    Time frame: Collected 12 months after birth in both offsprings

  104. Offspring blood sample - insulin

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Insulin

    Time frame: Collected 12 months after birth in both offsprings

  105. Offspring blood sample - IGF-1

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGF-1

    Time frame: Collected 12 months after birth in both offsprings

  106. Offspring blood sample - IGFBP-3

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGFBP-3

    Time frame: Collected 12 months after birth in both offsprings

  107. Offspring blood sample - IGFBP-1

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGFBP-1

    Time frame: Collected 12 months after birth in both offsprings

  108. Offspring blood sample - CD163

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for CD163

    Time frame: Collected 12 months after birth in both offsprings

  109. Offspring blood sample - Ferritin

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Ferritin

    Time frame: Collected 12 months after birth in both offsprings

  110. Offspring blood sample - HgbA1c

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for HgbA1c

    Time frame: Collected 12 months after birth in both offsprings

  111. Offspring blood sample - Hgb

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Hgb

    Time frame: Collected 12 months after birth in both offsprings

  112. Offspring blood sample - CRP

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for CRP

    Time frame: Collected 12 months after birth in both offsprings

  113. Offspring blood sample - Triglyceride

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Triglyceride

    Time frame: Collected 12 months after birth in both offsprings

  114. Offspring blood sample - Cholesterol HDL

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Cholesterol HDL

    Time frame: Collected 12 months after birth in both offsprings

  115. Offspring blood sample - Cholesterol LDL

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Cholesterol LDL

    Time frame: Collected 12 months after birth in both offsprings

  116. Offspring blood sample - Total Cholesterol

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Total Cholesterol

    Time frame: Collected 12 months after birth in both offsprings

  117. Offspring blood sample - FGF-21

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for FGF-21

    Time frame: Collected 12 months after birth in both offsprings

  118. Offspring blood sample - Leptin

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Leptin

    Time frame: Collected 12 months after birth in both offsprings

  119. Offspring blood sample - Adiponectin

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Adiponectin

    Time frame: Collected 12 months after birth in both offsprings

  120. Offspring blood sample - FFA

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for FFA

    Time frame: Collected 12 months after birth in both offsprings

  121. Offspring blood sample - Growth Hormone (GH)

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for GH

    Time frame: Collected 12 months after birth in both offsprings

  122. Offspring blood sample - cTroponin I (cTnI)

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for cTnI

    Time frame: Collected 12 months after birth in both offsprings

  123. Offspring blood sample - BNP

    A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for BNP

    Time frame: Collected 12 months after birth in both offsprings

  124. Cord blood - c-peptide

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for C-peptide

    Time frame: Collected at birth of both offspring

  125. Cord blood -Insulin

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Insulin

    Time frame: Collected at birth of both offspring

  126. Cord blood -IGFBP-3

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGFBP-3

    Time frame: Collected at birth of both offspring

  127. Cord blood -IGFBP-1

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGFBP-1

    Time frame: Collected at birth of both offspring

  128. Cord blood -IGF-1

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGF-1

    Time frame: Collected at birth of both offspring

  129. Cord blood -Ferritin

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Ferritin

    Time frame: Collected at birth of both offspring

  130. Cord blood -cTnI

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for cTnI

    Time frame: Collected at birth of both offspring

  131. Cord blood -BNP

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for BNP

    Time frame: Collected at birth of both offspring

  132. Cord blood -CRP

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for CRP

    Time frame: Collected at birth of both offspring

  133. Cord blood -CD163

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for CD163

    Time frame: Collected at birth of both offspring

  134. Cord blood -FGF21

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for FGF21

    Time frame: Collected at birth of both offspring

  135. Cord blood -Leptin

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Leptin

    Time frame: Collected at birth of both offspring

  136. Cord blood -Adiponectin

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Adiponectin

    Time frame: Collected at birth of both offspring

  137. Cord blood -FFA

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for FFA

    Time frame: Collected at birth of both offspring

  138. Cord blood - Vitamin D3

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Vitamin D3

    Time frame: Collected at birth of both offspring

  139. Cord blood - HbA1c

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for HbA1c

    Time frame: Collected at birth of both offspring

  140. Cord blood - IL-6

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-6

    Time frame: Collected at birth of both offspring

  141. Cord blood - IL-10

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-10

    Time frame: Collected at birth of both offspring

  142. Cord blood - IL-1 alpha

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-1 alpha

    Time frame: Collected at birth of both offspring

  143. Cord blood -TNF- alpha

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for-TNF- alpha

    Time frame: Collected at birth of both offspring

  144. Cord blood -IFN- gamma

    Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IFN- gamma

    Time frame: Collected at birth of both offspring

  145. Adult Controlled Attenuation Parameter (CAP)

    Liver composition is assessed using transient elastography with FibroScan hardware and software. Participants are examined in the supine position to obtain an intercostal view of the liver. Hepatic steatosis is defined as a CAP value \> 250 dB/m.

    Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy

  146. Adult kilopascal (kPa)

    Liver composition is assessed using transient elastography with FibroScan hardware and software. Participants are examined in the supine position to obtain an intercostal view of the liver.

    Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy

Other outcomes

  1. Offspring feces - Microbiome

    Will be analysed for microbiome. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  2. Offspring feces - Short chain fatty acids

    Will be analysed for short chain fatty acids. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  3. Offspring feces - Metabolomics

    Will be analysed for metabolomics. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  4. Offspring feces - Proteomics

    Will be analysed for proteomics. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  5. Offspring feces - pH

    Will be assessed for pH. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  6. Offspring feces - Inflammation markers

    Will be analysed for inflammation markers. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  7. Offspring feces - consistency

    Whenever a fecal sample is collected stool consistency of the collected sample will be collected with a questionnaire.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  8. Offspring feces - frequency

    Whenever a fecal sample is collected an estimate of stool frequency during the last week will be collected with a questionnaire.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  9. Offspring feces - gastrointestinal symptoms

    Whenever a fecal sample is collected any gastrointestinal symptoms of the offspring during the last week will be collected with a questionnaire.

    Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring

  10. Offspring urine

    Parents will be instructed to collect offspring's urine samples. A piece of bio-plastic will be placed in the diaper together with cotton balls to ensure that a sufficient amount of urine is absorbed into the cotton balls. Offspring urine will be analyzed for metabolomics.

    Time frame: Collected within the first week of birth and at 3 and 12 months follow up of each offspring

  11. Adult feces - Microbiome

    Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for microbiome.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  12. Adult feces - Short chain fatty acids

    Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for short chain fatty acids.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  13. Adult feces - Metabolomics

    Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for metabolomics

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  14. Adult feces - Proteomics

    Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for proteomics.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  15. Adult feces - Inflammation markers

    Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for inflammation markers.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  16. Adult feces - pH

    Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be assessed for pH.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  17. Adult feces - consistency

    Whenever a fecal sample is collected stool consistency of the collected sample will be collected with a questionnaire.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  18. Adult feces - frequency

    Whenever a fecal sample is collected an estimate of stool frequency during the last week will be collected with a questionnaire.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  19. Adult feces - gastrointestinal symptoms

    Whenever a fecal sample is collected gastrointestinal symptoms during the last week will be collected with a questionnaire.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  20. Adult urine

    Participants will collect a urine spot sample at the study site. Adult urine will be analyzed for metabolomics.

    Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child

  21. Offspring nutritional milestones

    Parents will be instructed to register the age of the offspring when it reaches the World Health Organization (WHO) nutritional milestones (age when the offspring was introduced to specific food items)

    Time frame: Collected at 12 and 18 months after offspring birth

  22. Offspring development, WHO milestones

    Parents will be instructed to register the age of the offspring when it reaches the World Health Organization (WHO) developmental milestones (age when the offspring can sit, stands in crawl-position, stands with support, stand alone, walk with support, walk alone)

    Time frame: Collected at 12 and 18 months after offspring birth

  23. Adult physical activity

    Physical activity and sleep will be assessed by an accelerometer and the females and males will wear the accelerometer for 7 days and 8 nights. The participants will be asked to keep a physical activity and sleep log for when they wake up and when they try to sleep

    Time frame: Collected at study visit 3, 12 and 24 months pp of 1st child

  24. Adult physical activity - Physical Activity Questionnaire (IPAQ)

    Physical activity will be assessed by the International Physical Activity Questionnaire (IPAQ), in which time spent on strenuous and moderate activity and walks will be collected. The answers will be collected electronic via RedCap.

    Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child

  25. Adult background quistionnaire, ethnicity,

    All information will be collected electronic in RedCap.

    Time frame: Collected after screening in GA34-GA36 of 1st child

  26. Adult background quistionnaire, education

    All information will be collected electronic in RedCap.

    Time frame: Collected after screening in GA34-GA36 of 1st child

  27. Adult background quistionnaire, parity

    All information will be collected electronic in RedCap.

    Time frame: Collected after screening in GA34-GA36 of 1st child

  28. Adult background quistionnaire, pre-pregnancy weight

    Pre-pregnancy weight, ethnicity, education and parity. All information will be collected electronic in RedCap.

    Time frame: Collected after screening in GA34-GA36 of 1st child

  29. Adult background quistionnaire, demographic information

    All information will be collected electronic in RedCap.

    Time frame: Collected after screening in GA34-GA36 of 1st child

  30. Adult wellbeing - Depression, Major depression questionnaire (ICD-10)

    Depression will be assessed by Major depression questionnaire (ICD-10). Mild depression: A score of 4 or 5 in two of the first three items. Plus a score of at least 3 on two or three of the last seven items. Moderate depression: A score of 4 or 5 in two or three of the first three items. Plus a score of at least 3 on four of the last seven items. Severe depression: A score of 4 or 5 in all of the first three items. Plus a score of at least 3 on five or more of the last seven items. Major depression: The number of items is reduced to nine, as Item 4 is part of Item 5. Include whichever of the two items has the highest score (item 4 or 5). A score on at least five items is required, to be scored as follows: the score on the first three items must be at least 4, and on the other items at least 3. Either Item 1 or 2 must have a score of 4 or 5.

    Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child

  31. Adult wellbeing - Quality of life, Short form-36 (SF-36)

    Quality of life will be assessed by the validated tool, Short form-36 (SF-36). The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child

  32. Adult wellbeing - Stress, Perceived Stress Scale

    Stress will be assessed by validated tool, Perceived Stress Scale.Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress

    Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child

  33. Adult sleep

    Sleep will be assessed by the validated tool, Pittsburgh sleep quality index questionnaire (PSQI). In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.

    Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child

  34. Adult dietary intake, 24-h recall

    A 24 hour dietary recall is performed by a trained dietitian. Dietary recall will be registered and intake calculated using the food data program 'VITAKOST' (www.vitakost.dk).

    Time frame: Collected at GA34-GA36 in each pregnancy, at visit 3, 12 and 24 months pp of the 1st child and 3 months visit after 2nd child. Further collected at 6, 18, 30 and 36 months pp and in GA12 and GA20 of 2nd pregnancy in intervention group

  35. Adult dietary intake, FFQ

    Couples will be asked to perform an electronic Food Frequency Questionnaire (FFQ). Information on frequence intake of various food groups during the last month will be collected.

    Time frame: Collected at GA34-GA36 in each pregnancy, at study visit 3, 12 and 24 months pp of the 1st child and 3 month follow up vist after 2nd child

  36. Offspring dietary intake

    We will collect information on offspring dietary intake including breast feeding, use of formula and type as well as use of antibiotics. The intake frequency of different foods will be collected throughout a children questionnaire.

    Time frame: Collected within the first week of birth and 3, 12 and 18 months after birth off each offspring

  37. Breast milk - nutrients biomarkers

    Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for nutrients biomarkers.

    Time frame: Collected within the first week of birth and 3 months pp after each birth

  38. Breast milk - Hormonal and inflammatory markers

    Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for hormonal and inflammatory markers

    Time frame: Collected within the first week of birth and 3 months pp after each birth

  39. Breast milk - Metabolomics

    Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for metabolomics

    Time frame: Collected within the first week of birth and 3 months pp after each birth

  40. Breast milk - Proteomics

    Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for proteomics.

    Time frame: Collected within the first week of birth and 3 months pp after each birth

  41. Breast milk - Short chain fatty acids and related metabolites

    Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for short chain fatty acids and related metabolites

    Time frame: Collected within the first week of birth and 3 months pp after each birth

  42. Adult participation - dietitian guidance

    It will be recorded how many times of individual and group dietitian guidance the participant attends

    Time frame: Every 1-2 month from 3 months pp of 1st child to birth of 2nd child

  43. Adult participation - physical session and self-reported physical activity

    It will be recorded how many times the participant participates in physical activity sessions and how many minutes of moderate physical activity a participant has performed the last week

    Time frame: At every dietitian visit from 3 months pp of 1st child to birth of 2nd child

08

Study locations

1 of 1 sites recruiting
  • Aarhus University Hospital
    Aarhus, 8200, Denmark
    Recruiting
    • Ulla K Opstrup · Contact
    • Ulla K Opstrup, MD, PhD · Principal investigator
09

References and documents

Publications

  • Rasmussen L, Knorr S, Antoniussen CS, Bruun JM, Ovesen PG, Fuglsang J, Kampmann U. The Impact of Lifestyle, Diet and Physical Activity on Epigenetic Changes in the Offspring-A Systematic Review. Nutrients. 2021 Aug 17;13(8):2821. doi: 10.3390/nu13082821. PubMed 34444981 ↗

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2023 (actual). Primary completion is estimated for Dec 2029, 78 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 78 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Apr 2025 → Dec 2029 and completion Apr 2028 → Dec 2030.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2023
First posted
Apr 4, 2023
StartActual
Jun 1, 2023
Primary completionEst.
Dec 30, 2029was Apr 2025
CompletionEst.
Dec 30, 2030was Apr 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Apr 11, 2025→Dec 30, 2029
Nov 12, 2026
Study completion
Apr 11, 2028→Dec 30, 2030
Nov 12, 2026
Enrollment
140→66
Nov 12, 2026
Eligibility
1 criterion edited
What changed in the criteria
  • EditedConnected to Aarhus University Hospital or Viborg Regional Hospital in Denmark as place of birth
Nov 12, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionDifference in epigenetic changes in child 1 and 2: how it is measured was reworded
Nov 12, 2026
Secondary outcomes
1 edited, 16 time frame changed, 2 added, 1 removed, 6 description edited
What changed in the outcomes
  • AddedAdult Controlled Attenuation Parameter (CAP)Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy
  • AddedAdult kilopascal (kPa)Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy
  • RemovedFetal growth - fractional limb volumeTime frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies,
  • Time frameFetal and offspring growth - body weightCollected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3, 12 and 18 months after birth of both offsprings → Collected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3 and 12 months after birth of both offsprings
  • Time frameFetal and offspring growth - lengthCollected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3, 12 and 18 months after birth of both offsprings → Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
  • Time frameFetal and offspring growth - abdominal circumferenceCollected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3, 12 and 18 months after birth of both offsprings → Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
  • Time frameFetal and offspring growth - crown circumferenceCollected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies → Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
  • Time frameOffspring growth - BMI z-scoreCollected at birth and 3, 12 and 18 months after birth of both offsprings → Collected at birth and 3 and 12 months after birth of both offsprings
  • Time frameOffspring growth - weight for gestational ageCollected at birth and 3, 12 and 18 months after birth of both offsprings → Collected at birth and 3 and 12 months after birth of both offsprings
  • Time frameOffspring growthCollected at birth and 3, 12 and 18 months after birth of offspring. → Collected at birth and 3 and 12 months after birth of offspring.
  • Time frameOffspring blood pressureCollected 12 and 18 months after birth of both offsprings → Collected 12 months after birth of both offsprings
  • Time frameOffspring heart rateCollected 12 and 18 months after birth of both offsprings → Collected 12 months after birth of both offsprings
  • Time frameOffspring growth - self-reported body weight18 months after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age → 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age
  • Time frameOffspring growth - self-reported height18 months after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age → 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age
  • Time frameAdult weightIntervention: each visit throughout study (GA34-36 of 1st child to 18mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3, 12 and 18 months pp of 2nd child) → Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)
  • Time frameAdult BMICollected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3, 12 and 18mo. pp of 2nd child). → Collected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3 and 12 mo. pp of 2nd child).
  • Time frameAdult anthropometricIntervention: each visit throughout study (GA34-36 of 1st child to 18mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3, 12 and 18 months pp of 2nd child) → Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)
  • Time frameOffspring medication useBirth, after 3, 12, and 18 months after birth of both offsprings → Birth, after 3 and 12 months after birth of both offsprings
  • Time frameAdult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female)Collected in GA28 of 1st and 2nd pregnancy (performed after risk score at gestational age~20 and ~28 or only ~28) → Collected in GA28 of 1st and 2nd pregnancy
  • DescriptionAdult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female): how it is measured was reworded
  • DescriptionAdult resting metabolic rate: how it is measured was reworded
  • DescriptionCord blood - pH: how it is measured was reworded
  • DescriptionFetal and offspring growth - crown circumference: how it is measured was reworded
  • DescriptionOffspring growth: how it is measured was reworded
  • DescriptionPlacenta - weight (gram): how it is measured was reworded
  • Editedother outcomeAdult participation - physical session and power walkself-reported physical activityTime frame: Every 2nd week from 3 months pp of 1st child to birth of 2nd child → At every dietitian visit from 3 months pp of 1st child to birth of 2nd child
Nov 12, 2026
Sponsor
Collaborators added: Aarhus University Hospital; collaborators removed: Jens Meldgaard Bruun, Professor Steno Diabetes Center Aarhus, Aarhus University Hospital·Sine Knorr, PhD Steno Diabetes Center Aarhus, Aarhus University Hospital
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Apr 11, 2025→Dec 30, 2029
    Study completion Apr 11, 2028→Dec 30, 2030
    Enrollment 140→66
    Eligibility 1 criterion edited
    What changed in the criteria
    • EditedConnected to Aarhus University Hospital or Viborg Regional Hospital in Denmark as place of birth
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionDifference in epigenetic changes in child 1 and 2: how it is measured was reworded
    Secondary outcomes 1 edited, 16 time frame changed, 2 added, 1 removed, 6 description edited
    What changed in the outcomes
    • AddedAdult Controlled Attenuation Parameter (CAP)Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy
    • AddedAdult kilopascal (kPa)Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy
    • RemovedFetal growth - fractional limb volumeTime frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies,
    • Time frameFetal and offspring growth - body weightCollected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3, 12 and 18 months after birth of both offsprings → Collected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3 and 12 months after birth of both offsprings
    • Time frameFetal and offspring growth - lengthCollected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3, 12 and 18 months after birth of both offsprings → Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
    • Time frameFetal and offspring growth - abdominal circumferenceCollected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3, 12 and 18 months after birth of both offsprings → Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
    • Time frameFetal and offspring growth - crown circumferenceCollected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies → Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
    • Time frameOffspring growth - BMI z-scoreCollected at birth and 3, 12 and 18 months after birth of both offsprings → Collected at birth and 3 and 12 months after birth of both offsprings
    • Time frameOffspring growth - weight for gestational ageCollected at birth and 3, 12 and 18 months after birth of both offsprings → Collected at birth and 3 and 12 months after birth of both offsprings
    • Time frameOffspring growthCollected at birth and 3, 12 and 18 months after birth of offspring. → Collected at birth and 3 and 12 months after birth of offspring.
    • Time frameOffspring blood pressureCollected 12 and 18 months after birth of both offsprings → Collected 12 months after birth of both offsprings
    • Time frameOffspring heart rateCollected 12 and 18 months after birth of both offsprings → Collected 12 months after birth of both offsprings
    • Time frameOffspring growth - self-reported body weight18 months after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age → 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age
    • Time frameOffspring growth - self-reported height18 months after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age → 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age
    • Time frameAdult weightIntervention: each visit throughout study (GA34-36 of 1st child to 18mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3, 12 and 18 months pp of 2nd child) → Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)
    • Time frameAdult BMICollected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3, 12 and 18mo. pp of 2nd child). → Collected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3 and 12 mo. pp of 2nd child).
    • Time frameAdult anthropometricIntervention: each visit throughout study (GA34-36 of 1st child to 18mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3, 12 and 18 months pp of 2nd child) → Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)
    • Time frameOffspring medication useBirth, after 3, 12, and 18 months after birth of both offsprings → Birth, after 3 and 12 months after birth of both offsprings
    • Time frameAdult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female)Collected in GA28 of 1st and 2nd pregnancy (performed after risk score at gestational age~20 and ~28 or only ~28) → Collected in GA28 of 1st and 2nd pregnancy
    • DescriptionAdult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female): how it is measured was reworded
    • DescriptionAdult resting metabolic rate: how it is measured was reworded
    • DescriptionCord blood - pH: how it is measured was reworded
    • DescriptionFetal and offspring growth - crown circumference: how it is measured was reworded
    • DescriptionOffspring growth: how it is measured was reworded
    • DescriptionPlacenta - weight (gram): how it is measured was reworded
    • Editedother outcomeAdult participation - physical session and power walkself-reported physical activityTime frame: Every 2nd week from 3 months pp of 1st child to birth of 2nd child → At every dietitian visit from 3 months pp of 1st child to birth of 2nd child
    Sponsor Collaborators added: Aarhus University Hospital; collaborators removed: Jens Meldgaard Bruun, Professor Steno Diabetes Center Aarhus, Aarhus University Hospital·Sine Knorr, PhD Steno Diabetes Center Aarhus, Aarhus University Hospital
    + 4 other changes: verification date, description, design details and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05798494
Lead sponsor
Ulla Kampmann Opstrup
Collaborators
Per Ovesen, Professor Dept. of Obsteterics, Aarhus University Hospital, Aarhus University Hospital
Responsible party
Ulla Kampmann Opstrup (Associate professor, University of Aarhus) — Sponsor-investigator
First posted
Apr 4, 2023
Start date
Jun 1, 2023
Primary completion
Dec 30, 2029 (estimated)
Completion
Dec 30, 2030 (estimated)
Last update
Nov 12, 2026

Study contacts

Ulla K Opstrup, MD, PhD
Contact
ullaopst@rm.dk
+4522370857
Louise Rasmussen, MSc
Contact
louisesuder@clin.au.dk
+4528731648
Ulla K Opstrup, Assoc
principal investigator · Aarhus University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion